Trademark: 78285531
Status Date
Monday, August 25, 2008
Filing Date
Monday, August 11, 2003
Published for Opposition
Tuesday, August 19, 2008
Abandoned Date
Friday, August 8, 2008
5 Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for medical use; pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer and auto-immune diseases in vivo immunotherapeutic, inimunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use vaccines; protein conjugates for the treatment of cancer and auto-immune diseases diagnostic and analytical preparations for medical and veterinary use, namely, products that diagnose and analyze the effects of cancer and tissue damage caused by inflammation due to auto-immune diseases; gene therapy and cell therapy products, namely, T-cell receptors-- enzymes and enzyme preparations for medical purposes for the treatment of cancer and auto-immune diseases for clinical or medical use; chemical products for use in medical science, namely, T-cell receptors small molecules and protein therapeutics for clinical or medical use, pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer and auto-immune diseases
10 Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring the spread of cancerous tissue, tissue damage or movement into affected limbs or organs; display apparatus, namely, multi-well plates and arrays for medical and clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors for medical purposes, medical and surgical syringes
42 Biotechnology services, research and development in biotechnology, namely, product research and development for others in the field of biotechnology; scientific and medical research and development for others in the field of biotechnology and genomics, pharmaceutical drug development services and pharmaceutical product development; genetic engineering services, licensing intellectual property including trademarks and patents in the field of biotechnology
Aug 25, 2008
Abandonment Notice Mailed - After Publication
Aug 25, 2008
Abandonment - After Publication
Aug 19, 2008
Published For Opposition
Aug 8, 2008
Teas Express Abandonment Received
Jul 30, 2008
Notice Of Publication
Jul 11, 2008
Law Office Publication Review Completed
Jul 10, 2008
Assigned To Lie
Jul 10, 2008
Approved For Pub - Principal Register
Jul 10, 2008
Examiners Amendment Mailed
Jul 9, 2008
Examiner's Amendment Entered
Jul 9, 2008
Examiners Amendment -Written
Jul 2, 2008
Previous Allowance Count Withdrawn
Jun 27, 2008
Withdrawn From Pub - Og Review Query
Jun 16, 2008
Law Office Publication Review Completed
Jun 9, 2008
Approved For Pub - Principal Register
May 19, 2008
Teas/Email Correspondence Entered
May 16, 2008
Correspondence Received In Law Office
May 16, 2008
Teas Response To Office Action Received
Dec 28, 2007
Non-Final Action Mailed
Dec 27, 2007
Non-Final Action Written
Nov 28, 2007
Assigned To Examiner
Nov 8, 2007
Teas/Email Correspondence Entered
Nov 8, 2007
Correspondence Received In Law Office
Nov 6, 2007
Teas Response To Office Action Received
Sep 19, 2007
Automatic Update Of Assignment Of Ownership
May 23, 2007
Report Completed Suspension Check Case Still Suspended
Nov 21, 2006
Report Completed Suspension Check Case Still Suspended
Nov 21, 2006
Assigned To Lie
Apr 29, 2006
Report Completed Suspension Check Case Still Suspended
Sep 14, 2005
Report Completed Suspension Check Case Still Suspended
Feb 23, 2005
Report Completed Suspension Check Case Still Suspended
Aug 23, 2004
Letter Of Suspension Mailed
Aug 12, 2004
Amendment From Applicant Entered
Jul 26, 2004
Correspondence Received In Law Office
Jul 26, 2004
Paper Received
Jan 26, 2004
Non-Final Action Mailed
Jan 24, 2004
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
